194 related articles for article (PubMed ID: 22927238)
21. Induction of apoptosis by bexarotene in cutaneous T-cell lymphoma cells: relevance to mechanism of therapeutic action.
Zhang C; Hazarika P; Ni X; Weidner DA; Duvic M
Clin Cancer Res; 2002 May; 8(5):1234-40. PubMed ID: 12006543
[TBL] [Abstract][Full Text] [Related]
22. Rexinoids modulate steroid and xenobiotic receptor activity by increasing its protein turnover in a calpain-dependent manner.
Pettersson F; Hanna N; Lagodich M; Dupéré-Richer D; Couture MC; Choi C; Miller WH
J Biol Chem; 2008 Aug; 283(32):21945-52. PubMed ID: 18544536
[TBL] [Abstract][Full Text] [Related]
23. The Novel RXR Agonist MSU-42011 Differentially Regulates Gene Expression in Mammary Tumors of MMTV-Neu Mice.
Reich LA; Leal AS; Ellsworth E; Liby KT
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901727
[TBL] [Abstract][Full Text] [Related]
24. The influence of bexarotene, a selective agonist of the retinoid receptor X (RXR), and tazarotene, a selective agonist of the retinoid acid receptor (RAR), on bone metabolism in rats.
Nowak B; Matuszewska A; Filipiak J; Nikodem A; Merwid-Ląd A; Pieśniewska M; Fereniec-Gołębiewska L; Kwiatkowska J; Szeląg A
Adv Med Sci; 2016 Mar; 61(1):85-9. PubMed ID: 26569440
[TBL] [Abstract][Full Text] [Related]
25. Bexarotene: a promising anticancer agent.
Qu L; Tang X
Cancer Chemother Pharmacol; 2010 Jan; 65(2):201-5. PubMed ID: 19777233
[TBL] [Abstract][Full Text] [Related]
26. Etiology, diagnosis, and treatment recommendations for central hypothyroidism associated with bexarotene therapy for cutaneous T-cell lymphoma.
Sherman SI
Clin Lymphoma; 2003 Mar; 3(4):249-52. PubMed ID: 12672276
[TBL] [Abstract][Full Text] [Related]
27. Rexinoids isolated from Sophora tonkinensis with a gene expression profile distinct from the synthetic rexinoid bexarotene.
Inoue M; Tanabe H; Nakashima K; Ishida Y; Kotani H
J Nat Prod; 2014 Jul; 77(7):1670-7. PubMed ID: 24959987
[TBL] [Abstract][Full Text] [Related]
28. Activation of the retinoid X receptor modulates angiotensin II-induced smooth muscle gene expression and inflammation in vascular smooth muscle cells.
Lehman AM; Montford JR; Horita H; Ostriker AC; Weiser-Evans MC; Nemenoff RA; Furgeson SB
Mol Pharmacol; 2014 Nov; 86(5):570-9. PubMed ID: 25169989
[TBL] [Abstract][Full Text] [Related]
29. Vorinostat combined with bexarotene for treatment of cutaneous T-cell lymphoma: in vitro and phase I clinical evidence supporting augmentation of retinoic acid receptor/retinoid X receptor activation by histone deacetylase inhibition.
Dummer R; Beyer M; Hymes K; Epping MT; Bernards R; Steinhoff M; Sterry W; Kerl H; Heath K; Ahern JD; Hardwick JS; Garcia-Vargas J; Baumann K; Rizvi S; Frankel SR; Whittaker SJ; Assaf C
Leuk Lymphoma; 2012 Aug; 53(8):1501-8. PubMed ID: 22239668
[TBL] [Abstract][Full Text] [Related]
30. Retinoids increase human apolipoprotein A-11 expression through activation of the retinoid X receptor but not the retinoic acid receptor.
Vu-Dac N; Schoonjans K; Kosykh V; Dallongeville J; Heyman RA; Staels B; Auwerx J
Mol Cell Biol; 1996 Jul; 16(7):3350-60. PubMed ID: 8668150
[TBL] [Abstract][Full Text] [Related]
31. Retinoid X Receptor agonists as selective modulators of the immune system for the treatment of cancer.
Leal AS; Hung PY; Chowdhury AS; Liby KT
Pharmacol Ther; 2023 Dec; 252():108561. PubMed ID: 37952906
[TBL] [Abstract][Full Text] [Related]
32. Synthesis of
Shibahara O; Watanabe M; Yamada S; Akehi M; Sasaki T; Akahoshi A; Hanada T; Hirano H; Nakatani S; Nishioka H; Takeuchi Y; Kakuta H
J Med Chem; 2017 Aug; 60(16):7139-7145. PubMed ID: 28753292
[TBL] [Abstract][Full Text] [Related]
33. Effects on gene expression in rat liver after administration of RXR agonists: UAB30, 4-methyl-UAB30, and Targretin (Bexarotene).
Vedell PT; Lu Y; Grubbs CJ; Yin Y; Jiang H; Bland KI; Muccio DD; Cvetkovic D; You M; Lubet R
Mol Pharmacol; 2013 Mar; 83(3):698-708. PubMed ID: 23292798
[TBL] [Abstract][Full Text] [Related]
34. Retinoic acid isomers facilitate apolipoprotein E production and lipidation in astrocytes through the retinoid X receptor/retinoic acid receptor pathway.
Zhao J; Fu Y; Liu CC; Shinohara M; Nielsen HM; Dong Q; Kanekiyo T; Bu G
J Biol Chem; 2014 Apr; 289(16):11282-11292. PubMed ID: 24599963
[TBL] [Abstract][Full Text] [Related]
35. Retinoid X receptor ligands: a patent review (2007 - 2013).
Yamada S; Kakuta H
Expert Opin Ther Pat; 2014 Apr; 24(4):443-52. PubMed ID: 24456080
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of Integrin αVβ3 Signaling Improves the Antineoplastic Effect of Bexarotene in Cutaneous T-Cell Lymphoma.
Cayrol F; Revuelta MV; Debernardi M; Paulazo A; Phillip JM; Zamponi N; Sterle H; Díaz Flaqué MC; Magro C; Marullo R; Mulvey E; Ruan J; Cremaschi GA; Cerchietti L
Mol Cancer Ther; 2022 Sep; 21(9):1485-1496. PubMed ID: 35793463
[TBL] [Abstract][Full Text] [Related]
37. Methods to Assess Activity and Potency of Rexinoids Using Rapid Luciferase-Based Assays: A Case Study with NEt-TMN.
Jurutka PW; Wagner CE
Methods Mol Biol; 2019; 2019():95-108. PubMed ID: 31359391
[TBL] [Abstract][Full Text] [Related]
38. [Advances in studies on selective RXR ligands].
Mei JH; Wang MW
Yao Xue Xue Bao; 2005 Apr; 40(4):294-8. PubMed ID: 16011254
[No Abstract] [Full Text] [Related]
39. Bexarotene.
Lowe MN; Plosker GL
Am J Clin Dermatol; 2000; 1(4):245-50; discussion 251-2. PubMed ID: 11702369
[TBL] [Abstract][Full Text] [Related]
40. Rexinoid bexarotene modulates triglyceride but not cholesterol metabolism via gene-specific permissivity of the RXR/LXR heterodimer in the liver.
Lalloyer F; Pedersen TA; Gross B; Lestavel S; Yous S; Vallez E; Gustafsson JA; Mandrup S; Fiévet C; Staels B; Tailleux A
Arterioscler Thromb Vasc Biol; 2009 Oct; 29(10):1488-95. PubMed ID: 19592467
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
